Bank of Nova Scotia (0UKI)
London Exchange · UK · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 130.87 |
|---|---|
| 52-week range | 90.22 – 134.41 |
| Return, 1 month / 3 months | −0.7% / +7.3% |
| Return, 1 year / 3 years | +51.0% / +158.9% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 17.4% |
| Worst drawdown (1 year) | -11.5% |
| Average daily value traded | 0.31M CAD |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank of Nova Scotia is a Canadian bank based in Toronto. It provides personal and commercial banking, wealth management, insurance and investment banking services to individuals, businesses and institutional clients. Its operations span Canada, the United States, Latin America, the Caribbean and other international markets, with a notable retail and commercial presence in Mexico, Peru, Chile and Colombia. The bank also offers lending, deposits, credit cards, mortgages and capital markets services.
Bank of Nova Scotia trades under the code 0UKI on the London Exchange in UK, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank of Nova Scotia (0UKI) trades on the London Exchange in UK. It last closed at CAD 130.87 on 22 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 91 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.0% and over the last three months it rose 7.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.2% | ||
| From 52-week high | -2.1% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.3% | ||
| 6-month return | 29.0% | ||
| 12-month return, skipping the last month | 52.1% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.5% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.31M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | −0.7% |
| 3 months | +7.3% |
| 6 months | +29.0% |
| 1 year | +51.0% |
| 3 years | +158.9% |
| 5 years | +123.0% |
Signals
| 50-day / 200-day average | 127.50 / 111.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Oct 2026 | CAD 1.1400 |
| 7 Jul 2026 | CAD 1.1400 |
| 7 Apr 2026 | CAD 1.1000 |
| 5 Jan 2026 | CAD 1.1000 |
| 7 Oct 2025 | CAD 1.1000 |
| 2 Jul 2025 | CAD 1.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.